Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 3
This trial is for people with triple negative breast cancer who are going to have treatment for the first time. Triple negative breast cancers are cancers whose cells don’t have receptors for:
the hormones oestrogen and progesterone
the Her 2 protein
Recruitment start: 26 October 2017
Recruitment end: 12 June 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Samreen Ahmed
Roche
Last reviewed: 6 October 2020
CRUK internal database number: 16405